Stay updated on CJM112 in Hidradenitis Suppurativa Patients Clinical Trial
Sign up to get notified when there's something new on the CJM112 in Hidradenitis Suppurativa Patients Clinical Trial page.

Latest updates to the CJM112 in Hidradenitis Suppurativa Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedGlossary visibility was added and QC milestone entries (First Submitted that Met QC Criteria, Results First Submitted that Met QC Criteria, Last Update Submitted that Met QC Criteria) were recorded. A revision update to v3.4.0 occurred, and the No FEAR Act data label appeared briefly and was removed.SummaryDifference0.2%

- Check20 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 in the page header. No substantive content changes are indicated by the screenshots.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded Revision: v3.3.3. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.3.2 updated on the site, with no visible changes to page content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange Detected- Added Revision: v3.3.1 and removed Revision: v3.2.0 from the page.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded detailed numerical data and tables for pharmacokinetics (Ctrough), immunogenicity (ADA), and IL-17A levels, along with expanded outcome measures and participant counts for Period 1 and Period 2.SummaryDifference1%

Stay in the know with updates to CJM112 in Hidradenitis Suppurativa Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CJM112 in Hidradenitis Suppurativa Patients Clinical Trial page.